Maryland State Retirement & Pension System’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.96M Hold
6,021
0.04% 332
2025
Q1
$1.63M Sell
6,021
-969
-14% -$262K 0.04% 347
2024
Q4
$1.64M Sell
6,990
-203
-3% -$47.8K 0.04% 399
2024
Q3
$1.98M Sell
7,193
-2,643
-27% -$727K 0.04% 359
2024
Q2
$2.39M Hold
9,836
0.04% 342
2024
Q1
$1.44M Buy
9,836
+385
+4% +$56.4K 0.03% 484
2023
Q4
$1.81M Hold
9,451
0.04% 395
2023
Q3
$1.67M Hold
9,451
0.04% 392
2023
Q2
$1.8M Sell
9,451
-214
-2% -$40.6K 0.04% 399
2023
Q1
$1.94M Hold
9,665
0.04% 352
2022
Q4
$2.3M Buy
9,665
+305
+3% +$72.5K 0.07% 270
2022
Q3
$1.87M Buy
9,360
+261
+3% +$52.2K 0.16% 110
2022
Q2
$1.33M Hold
9,099
0.04% 392
2022
Q1
$1.49M Hold
9,099
0.04% 416
2021
Q4
$1.54M Buy
9,099
+272
+3% +$46.1K 0.04% 427
2021
Q3
$1.62M Hold
8,827
0.05% 380
2021
Q2
$1.54M Hold
8,827
0.05% 364
2021
Q1
$1.25M Buy
8,827
+6,965
+374% +$983K 0.04% 412
2020
Q4
$288K Buy
+1,862
New +$288K 0.05% 350